Provided by Tiger Trade Technology Pte. Ltd.

Bio-Techne

72.40
-0.0700-0.10%
Post-market: 72.470.0700+0.10%19:30 EDT
Volume:2.71M
Turnover:196.38M
Market Cap:11.35B
PE:62.41
High:72.54
Open:72.50
Low:72.38
Close:72.47
52wk High:72.69
52wk Low:43.20
Shares:156.82M
Float Shares:155.81M
Volume Ratio:0.88
T/O Rate:1.74%
Dividend:0.32
Dividend Rate:0.44%
EPS(TTM):1.16
EPS(LYR):1.16
ROE:9.03%
ROA:6.67%
PB:5.39
PE(LYR):62.41

Loading ...

Bio-Techne Releases Fourth Quarter Fiscal 2026 Results

THOMSON REUTERS
·
Aug 12

U.S. Earnings Preview: Before Market Open Aug. 12

Dow Jones
·
Aug 12

Bio-Techne (TECH) Stock Could Be 21% Above Fair Value On Earnings And Cash Flow

Simply Wall St.
·
Aug 08

Table: G-TECH Optoelectronics Jul Rev Nt$213.9m vs Nt$172.4m

Dow Jones
·
Aug 07

Merck Raises 2026 Profit Guidance, Beats Quarterly Estimates

Reuters
·
Aug 06

Cognizant Launches EMEA AI Unit to Scale Agentic AI Adoption Across Europe, Middle East, Africa

Reuters
·
Jul 28

Press Release: Groupe Dynamite Appoints AI and TECH Leader, MR. Martin KON, to ITS BOARD of Directors

Dow Jones
·
Jul 23

Repligen Beefs up Cell Therapy Business with $1.5 Billion Deal for Biolife

Reuters
·
Jul 22

Press Release: YSX TECH. CO. LTD Reports Full Year 2026 Financial Results

Dow Jones
·
Jul 11

RBC Capital Downgrades Bio-Techne to Sector Perform From Outperform, Adjusts Price Target to $73 From $62

MT Newswires Live
·
Jul 09

U.S. Research Roundup-applied Materials, CME Group, NASDAQ

Reuters
·
Jul 09

Bio-techne Corp : RBC Cuts to Sector Perform from Outperform; Raises Target Price to $73 from $62

THOMSON REUTERS
·
Jul 09

Bio-Techne Expands AI-Engineered Designer Protein Portfolio

MT Newswires Live
·
Jul 08

Evercore ISI Downgrades Bio-Techne to In Line From Outperform, Maintains $73 Price Target

MT Newswires Live
·
Jul 06

Merck KGaA downgraded to Hold from Buy at HSBCBio-Techne

TIPRANKS
·
Jul 06

Piper Sandler Adjusts Bio-Techne Price Target to $73 From $60, Maintains Neutral Rating

MT Newswires Live
·
Jul 01

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bio-Techne (TECH), Concentra Group Holdings Parent, Inc. (CON) and Palvella Therapeutics (PVLA)

TIPRANKS
·
Jul 01

Merck Kgaa Agrees to Buy Bio-techne for USD 73 a Share in Cash

Reuters
·
Jul 01

Bio-techne Cut to Hold from Buy by Benchmark

Dow Jones
·
Jun 30

Benchmark Downgrades Bio-Techne to Hold From Buy

MT Newswires Live
·
Jun 30